Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Liberty Broadband CorpCOM SER C | 184,460 | 1,886,260 | +1,701,800 | $14.87M | $107.95M | 27.68% | +$93.09M |
| Springworks Therapeutics Inc | 556,928 | 592,528 | +35,600 | $20.33M | $29.16M | 7.48% | +$8.84M |
| Ascendis Pharma A/SADR(ASND) | 163,772 | 175,672 | +11,900 | $20.63M | $26.56M | 6.81% | +$5.93M |
| Arvinas, Inc.(ARVN) | 504,700 | 539,100 | +34,400 | $20.77M | $22.25M | 5.71% | +$1.48M |
| Revolution Medicines, Inc.(RVMD) | 617,100 | 677,100 | +60,000 | $17.70M | $21.82M | 5.60% | +$4.12M |
| Sarepta Therapeutics, Inc.(SRPT) | 145,357 | 158,457 | +13,100 | $14.02M | $20.51M | 5.26% | +$6.50M |
| argenx SEADR(ARGX) | 0 | 50,000 | +50,000 | $0 | $19.69M | 5.05% | +$19.69M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 895,000 | 360,916 | -534,084 | $62.7K | $18.13M | 4.65% | +$18.07M |
| Cytokinetics, Incorporated(CYTK) | 431,693 | 238,046 | -193,647 | $36.04M | $16.69M | 4.28% | -$19.35M |
| Lakefront Biotherapeutics NVADR(LKFT) | 458,659 | 503,759 | +45,100 | $18.64M | $16.22M | 4.16% | -$2.42M |
| Acadia Pharmaceuticals Inc | 769,653 | 840,453 | +70,800 | $24.10M | $15.54M | 3.99% | -$8.56M |
| EyePoint, Inc.(EYPT) | 0 | 656,600 | +656,600 | $0 | $13.57M | 3.48% | +$13.57M |
| Dish Network CorporationNOTE 12 1 | 0 | 0 | 0 | $0 | $13.45M | 3.45% | +$13.45M |
| Solid Biosciences Inc | 961,251 | 961,251 | 0 | $5.90M | $12.80M | 3.28% | +$6.90M |
| Travere Therapeutics, Inc.(TVTX) | 1,435,321 | 1,649,221 | +213,900 | $12.90M | $12.72M | 3.26% | -$188.0K |
| Relay Therapeutics, Inc.(RLAY) | 1,317,870 | 1,490,170 | +172,300 | $14.51M | $12.37M | 3.17% | -$2.14M |
| Prothena Corp PlcSHS SHS | 349,300 | 402,400 | +53,100 | $12.69M | $9.97M | 2.56% | -$2.73M |
| Churchill Capital Corp ViiW EXP 02 29 202 | 548,000 | 548,000 | 0 | $71.3K | $175.4K | 0.04% | +$104.1K |
| Moneyhero LimitedW EXP 09 13 202 *W EXP 09/13/202 | 0 | 895,000 | +895,000 | $0 | $108.5K | 0.03% | +$108.5K |
| Calidi Biotherapeutics Inc | 125,000 | 125,000 | 0 | $188.8K | $70.6K | 0.02% | -$118.1K |
| Concord Acquisition Corp IIW EXP 99 99 999(CNDA) | 408,333 | 408,333 | 0 | $53.1K | $45.4K | 0.01% | -$7.6K |
| Compass Digital Acquisition CorpW EXP 09 29 202 | 459,906 | 459,906 | 0 | $22.3K | $42.3K | 0.01% | +$20.1K |
| Calidi Biotherapeutics IncW EXP 03 14 202 | 655,200 | 655,200 | 0 | $32.8K | $34.1K | 0.01% | +$1.3K |
| Swiftmerge Acquisition CorpW EXP 12 13 202 | 490,000 | 490,000 | 0 | $20.1K | $27.4K | 0.01% | +$7.3K |
| Ys Biopharma Co LtdW EXP 03 15 202 | 489,999 | 489,999 | 0 | $13.3K | $25.0K | 0.01% | +$11.7K |
| Marblegate Acquisition CorpW EXP 08 31 202 | 735,000 | 735,000 | 0 | $22.1K | $8.2K | 0.00% | -$13.8K |
| Amicus Therapeutics Inc COM | 1,489,025 | 0 | -1,489,025 | $21.13M | $0 | — | -$21.13M |
| Home Plate Acquisition CorpW EXP 09 30 202 | 331,416 | 0 | -331,416 | $20.01M | $0 | — | -$20.01M |
| Morphic Holding Inc | 496,856 | 0 | -496,856 | $14.35M | $0 | — | -$14.35M |
| Ross Acquisition Corp IiW EXP 02 01 202 | 439,666 | 0 | -439,666 | $24.6K | $0 | — | -$24.6K |